# Unisys Corp: financial statements, quarterly

UIS · NYSE · CIK 746838 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uis.md) · [Financials](/companies/uis/financials.md) · [Filings](/companies/uis/filings.md) · [Insiders](/companies/uis/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uis/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [465](/filings/0000746838-24-000030.md) | [267 d](/filings/0000746838-24-000005.md) | [488](/filings/0001628280-25-021581.md) | [478](/filings/0000746838-25-000020.md) | [497](/filings/0000746838-25-000030.md) | [545 d](/filings/0000746838-26-000006.md) | [432](/filings/0000746838-26-000018.md) | [483](/filings/0000746838-26-000027.md) | [460](/filings/0000746838-25-000030.md) | [575 d](/filings/0000746838-26-000006.md) | [438](/filings/0000746838-26-000018.md) | [474](/filings/0000746838-26-000027.md) |
| Cost of revenue | $m | [369](/filings/0000746838-24-000030.md) | [376 d](/filings/0000746838-26-000006.md) | [352](/filings/0001628280-25-021581.md) | [348](/filings/0000746838-25-000020.md) | [352](/filings/0000746838-25-000030.md) | [370 d](/filings/0000746838-26-000006.md) | [325](/filings/0000746838-26-000018.md) | [353](/filings/0000746838-26-000027.md) | [343](/filings/0000746838-25-000030.md) | [380 d](/filings/0000746838-26-000006.md) | [325](/filings/0000746838-26-000018.md) | [356](/filings/0000746838-26-000027.md) |
| Gross profit | $m | [95.3](/filings/0000746838-24-000030.md) | [181 d](/filings/0000746838-26-000006.md) | [136](/filings/0001628280-25-021581.md) | [130](/filings/0000746838-25-000020.md) | [145](/filings/0000746838-25-000030.md) | [175 d](/filings/0000746838-26-000006.md) | [108](/filings/0000746838-26-000018.md) | [130](/filings/0000746838-26-000027.md) | [117](/filings/0000746838-25-000030.md) | [195 d](/filings/0000746838-26-000006.md) | [113](/filings/0000746838-26-000018.md) | [117](/filings/0000746838-26-000027.md) |
| Research and development | $m | [4.3](/filings/0000746838-24-000030.md) | [8.2 d](/filings/0000746838-26-000006.md) | [6.1](/filings/0001628280-25-021581.md) | [4.9](/filings/0000746838-25-000020.md) | [6.5](/filings/0000746838-25-000030.md) | [7.7 d](/filings/0000746838-26-000006.md) | [5.6](/filings/0000746838-26-000018.md) | [6.1](/filings/0000746838-26-000027.md) | [4.8](/filings/0000746838-25-000030.md) | [8.1 d](/filings/0000746838-26-000006.md) | [4.8](/filings/0000746838-26-000018.md) | [5.8](/filings/0000746838-26-000027.md) |
| Selling, general and administrative | $m | [108](/filings/0000746838-24-000030.md) | [129 d](/filings/0000746838-26-000006.md) | [112](/filings/0001628280-25-021581.md) | [101](/filings/0000746838-25-000020.md) | [91.9](/filings/0000746838-25-000030.md) | [119 d](/filings/0000746838-26-000006.md) | [96.8](/filings/0000746838-26-000018.md) | [93.6](/filings/0000746838-26-000027.md) | [90.9](/filings/0000746838-25-000030.md) | [110 d](/filings/0000746838-26-000006.md) | [91.5](/filings/0000746838-26-000018.md) | [95.7](/filings/0000746838-26-000027.md) |
| Operating income | $m | [(17.1)](/filings/0000746838-24-000030.md) | [44.0 d](/filings/0000746838-26-000006.md) | [17.7](/filings/0001628280-25-021581.md) | [23.6](/filings/0000746838-25-000020.md) | [7.5](/filings/0000746838-25-000030.md) | [48.6 d](/filings/0000746838-26-000006.md) | [5.1](/filings/0000746838-26-000018.md) | [30.3](/filings/0000746838-26-000027.md) | [(33.5)](/filings/0000746838-25-000030.md) | [76.6 d](/filings/0000746838-26-000006.md) | [16.2](/filings/0000746838-26-000018.md) | [(32.9)](/filings/0000746838-26-000027.md) |
| Interest expense | $m | [7.8](/filings/0000746838-23-000050.md) | [7.9 d](/filings/0000746838-24-000005.md) | [7.9](/filings/0000746838-24-000013.md) | [7.9](/filings/0000746838-25-000020.md) | [7.9](/filings/0000746838-25-000030.md) | [8.2 d](/filings/0000746838-26-000006.md) | [8.2](/filings/0000746838-26-000018.md) | [8.2](/filings/0000746838-26-000027.md) | [18.2](/filings/0000746838-25-000030.md) | [18.8 d](/filings/0000746838-26-000006.md) | [18.5](/filings/0000746838-26-000018.md) | [18.3](/filings/0000746838-26-000027.md) |
| Income tax | $m | [20.4](/filings/0000746838-24-000030.md) | [23.6 d](/filings/0000746838-26-000006.md) | [17.0](/filings/0001628280-25-021581.md) | [18.8](/filings/0000746838-25-000020.md) | [53.3](/filings/0000746838-25-000030.md) | [28.8 d](/filings/0000746838-26-000006.md) | [10.6](/filings/0000746838-26-000018.md) | [20.0](/filings/0000746838-26-000027.md) | [16.3](/filings/0000746838-25-000030.md) | [20.9 d](/filings/0000746838-26-000006.md) | [13.7](/filings/0000746838-26-000018.md) | [15.8](/filings/0000746838-26-000027.md) |
| Net income | $m | [(50.0)](/filings/0000746838-24-000030.md) | [(165) d](/filings/0000746838-26-000006.md) | [(150)](/filings/0001628280-25-021581.md) | [(12.0)](/filings/0000746838-25-000020.md) | [(61.9)](/filings/0000746838-25-000030.md) | [30.0 d](/filings/0000746838-26-000006.md) | [(29.5)](/filings/0000746838-26-000018.md) | [(20.1)](/filings/0000746838-26-000027.md) | [(309)](/filings/0000746838-25-000030.md) | [18.7 d](/filings/0000746838-26-000006.md) | [(35.8)](/filings/0000746838-26-000018.md) | [(95.3)](/filings/0000746838-26-000027.md) |
| Diluted EPS | $ per share | [(0.73)](/filings/0000746838-24-000030.md) | not reported | [(2.18)](/filings/0001628280-25-021581.md) | [(0.17)](/filings/0000746838-25-000020.md) | [(0.89)](/filings/0000746838-25-000030.md) | not reported | [(0.42)](/filings/0000746838-26-000018.md) | [(0.28)](/filings/0000746838-26-000027.md) | [(4.33)](/filings/0000746838-25-000030.md) | not reported | [(0.50)](/filings/0000746838-26-000018.md) | [(1.31)](/filings/0000746838-26-000027.md) |
| Basic EPS | $ per share | [(0.73)](/filings/0000746838-24-000030.md) | not reported | [(2.18)](/filings/0001628280-25-021581.md) | [(0.17)](/filings/0000746838-25-000020.md) | [(0.89)](/filings/0000746838-25-000030.md) | not reported | [(0.42)](/filings/0000746838-26-000018.md) | [(0.28)](/filings/0000746838-26-000027.md) | [(4.33)](/filings/0000746838-25-000030.md) | not reported | [(0.50)](/filings/0000746838-26-000018.md) | [(1.31)](/filings/0000746838-26-000027.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [385](/filings/0000746838-23-000050.md) | [388](/filings/0000746838-25-000008.md) | [383](/filings/0000746838-24-000013.md) | [345](/filings/0000746838-24-000023.md) | [374](/filings/0000746838-24-000030.md) | [377](/filings/0000746838-26-000006.md) | [393](/filings/0001628280-25-021581.md) | [301](/filings/0000746838-25-000020.md) | [322](/filings/0000746838-25-000030.md) | [414](/filings/0000746838-26-000027.md) | [380](/filings/0000746838-26-000018.md) | [324](/filings/0000746838-26-000027.md) |
| Current assets | $m | [892](/filings/0000746838-23-000050.md) | [971](/filings/0000746838-25-000008.md) | [920](/filings/0000746838-24-000013.md) | [908](/filings/0000746838-24-000023.md) | [947](/filings/0000746838-24-000030.md) | [979](/filings/0000746838-26-000006.md) | [950](/filings/0001628280-25-021581.md) | [896](/filings/0000746838-25-000020.md) | [866](/filings/0000746838-25-000030.md) | [1,004](/filings/0000746838-26-000027.md) | [896](/filings/0000746838-26-000018.md) | [846](/filings/0000746838-26-000027.md) |
| Total assets | $m | [1,971](/filings/0000746838-23-000050.md) | [1,965](/filings/0000746838-25-000008.md) | [1,891](/filings/0000746838-24-000013.md) | [1,868](/filings/0000746838-24-000023.md) | [1,862](/filings/0000746838-24-000030.md) | [1,872](/filings/0000746838-26-000006.md) | [1,840](/filings/0001628280-25-021581.md) | [1,797](/filings/0000746838-25-000020.md) | [1,744](/filings/0000746838-25-000030.md) | [1,846](/filings/0000746838-26-000027.md) | [1,732](/filings/0000746838-26-000018.md) | [1,642](/filings/0000746838-26-000027.md) |
| Current liabilities | $m | [640](/filings/0000746838-23-000050.md) | [651](/filings/0000746838-25-000008.md) | [590](/filings/0000746838-24-000013.md) | [592](/filings/0000746838-24-000023.md) | [585](/filings/0000746838-24-000030.md) | [628](/filings/0000746838-26-000006.md) | [568](/filings/0001628280-25-021581.md) | [540](/filings/0000746838-25-000020.md) | [564](/filings/0000746838-25-000030.md) | [656](/filings/0000746838-26-000027.md) | [602](/filings/0000746838-26-000018.md) | [600](/filings/0000746838-26-000027.md) |
| Long-term debt | $m | not reported | [504](/filings/0000746838-24-000005.md) | not reported | not reported | not reported | [490](/filings/0000746838-25-000008.md) | not reported | not reported | not reported | [701](/filings/0000746838-26-000006.md) | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(32.4)](/filings/0000746838-23-000050.md) | [(152)](/filings/0000746838-25-000008.md) | [(159)](/filings/0000746838-24-000013.md) | [(174)](/filings/0000746838-24-000023.md) | [(202)](/filings/0000746838-24-000030.md) | [(283)](/filings/0000746838-26-000006.md) | [(268)](/filings/0001628280-25-021581.md) | [(222)](/filings/0000746838-25-000020.md) | [(300)](/filings/0000746838-25-000030.md) | [(283)](/filings/0000746838-26-000027.md) | [(300)](/filings/0000746838-26-000018.md) | [(367)](/filings/0000746838-26-000027.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(4.1) d](/filings/0000746838-24-000030.md) | [23.0 d](/filings/0000746838-26-000006.md) | [23.8](/filings/0001628280-25-021581.md) | [2.7 d](/filings/0000746838-25-000020.md) | [32.0 d](/filings/0000746838-25-000030.md) | [76.6 d](/filings/0000746838-26-000006.md) | [33.3](/filings/0000746838-26-000018.md) | [(316) d](/filings/0000746838-26-000027.md) | [38.0 d](/filings/0000746838-25-000030.md) | [105 d](/filings/0000746838-26-000006.md) | [(4.4)](/filings/0000746838-26-000018.md) | [(26.3) d](/filings/0000746838-26-000027.md) |
| Capital expenditure | $m | [3.5 d](/filings/0000746838-24-000030.md) | [17.3 d](/filings/0000746838-26-000006.md) | [6.7](/filings/0001628280-25-021581.md) | [8.7 d](/filings/0000746838-25-000020.md) | [6.8 d](/filings/0000746838-25-000030.md) | [10.1 d](/filings/0000746838-26-000006.md) | [8.9](/filings/0000746838-26-000018.md) | [7.9 d](/filings/0000746838-26-000027.md) | [5.6 d](/filings/0000746838-25-000030.md) | [7.6 d](/filings/0000746838-26-000006.md) | [10.7](/filings/0000746838-26-000018.md) | [12.0 d](/filings/0000746838-26-000027.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [67.8](/filings/0000746838-23-000050.md) | [67.9](/filings/0000746838-24-000013.md) | [68.3](/filings/0000746838-24-000023.md) | [68.4](/filings/0000746838-24-000030.md) | [68.7](/filings/0001628280-25-021581.md) | [69.3](/filings/0000746838-25-000020.md) | [69.4](/filings/0000746838-25-000030.md) | [70.1](/filings/0000746838-26-000018.md) | [71.3](/filings/0000746838-26-000027.md) | [71.3](/filings/0000746838-25-000030.md) | [71.8](/filings/0000746838-26-000018.md) | [72.9](/filings/0000746838-26-000027.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 72,915,955 at 2026-06-30, from the cover of the [10-Q filed 2026-07-30](/filings/0000746838-26-000027.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.